aerovatetx.com (JBIO) Company Sales Volume

Corporate emblem and logo of Aerovate Therapeutics, Inc. (JBIO)

Aerovate Therapeutics Inc (JBIO) develops advanced inhalation therapies to combat pulmonary hypertension. The company's aggregate sales revenue demonstrates current performance trends, where the value 0.00 reflects the metric's balance. The development of new molecules in the United States relies on patent protection. However, the lack of profitability and the current stage of clinical trials force the business to strictly conserve its existing reserves.

JBIO Aerovate: Revenue and Sales Volume in the range 04/30/2025 - 11/18/2026

Analytical breakdowns for Aerovate Therapeutics Inc

- price and consensus price forecast:
Comprehensive company analysis:JBIO (Aerovate)
Original product of Aerovate Therapeutics Inc

This indicator captures daily market equilibrium, determining the actual purchasing power of clients without accounting distortions. Investors compare this trend with business resilience to assess asset liquidity. An analysis of the company's current performance metrics allows for the identification of hidden gaps in fundamental factors. For Aerovate Therapeutics Inc (JBIO), a sharp decline in the metric reflects the loss of the patient base following failed trials. The recovery of the trend now depends directly on the approval of new FDA plans.

Competing companies

Revenue and Sales Volume argenx.com|Company Revenue BioNTech Group (BNTX)|Abivax S.A. - Company Sales Volume|Revenue and Sales Volume ADMA (admabiologics.com)|Protagonist Corp (PTGX) - Company Total Revenue|immunovant.com - Revenue and Sales Volume|KNSA - Revenue and Sales Volume|Grifols (GRFS) - Company Revenue|Company Sales Volume ADPT|Company Revenue Celldex|AUPH: Company Sales Revenue|Revenue and Sales Volume BCRX|Revenue and Sales Volume Vera Therapeutics (VERA)|Dianthus Therapeutics - Company Sales|Pharvaris - Company Revenue|ABCL - Company Revenue|TRML - Revenue and Sales Volume|PGEN: Revenue and Sales Volume|Company Sales Volume PHAR|Company Sales NKTR|UPB: Company Sales Revenue|Company Revenue zenasbio.com (ZBIO)|IMNM (Immunome Corp) - Company Sales Revenue|Revenue and Sales Volume GOSS (Gossamer Bio, Inc.)|KALV (KalVista Pharmaceuticals) - Company Annual Revenue|SEPN - Company Revenue|Company Sales Revenue PVLA (Pieris Pharma)|Savara Pharma (SVRA) - Company Revenue|Rigel Pharmaceuticals Inc (RIGL) - Revenue and Sales Volume|Company Revenue AnaptysBio|Astria Therapeutics - Company Annual Revenue|Revenue and Sales Volume ENGN|Company Total Sales RAPT|Revenue and Sales Volume ACRS (aclaristx.com)|Kyverna Therapeutics (KYTX) - Company Total Revenue|tizianalifesciences.com - Revenue and Sales Volume|CABA (Cabaletta Bio, Inc.) - Company Sales Volume|VTYX: Revenue and Sales Volume|THTX - Company Gross Revenue|Company Revenue Avalo Therapeutics Inc|Eledon (ELDN) - Company Gross Revenue|Company Revenue agenusbio.com (AGEN)|CLYM (Climb Bio Inc) - Company Sales Revenue|Revenue and Sales Volume ZURA (zurabio.com)|Company Sales Revenue ATYR|ADAG - Company Revenue|ikenaoncology.com (IMA) - Company Sales|Shattuck Labs (STTK) - Company Revenue|EQ - Company Gross Revenue|CNTB (connectbiopharm.com) - Revenue and Sales Volume|IMUX: Company Sales Revenue|Company Revenue Atara Biotherapeutics, Inc. (ATRA)|Company Gross Revenue InflaRx NV|Revenue and Sales Volume XFOR (X4 Pharmaceuticals)|Revenue and Sales Volume Adicet Bio ACET|CELU: Company Sales|Company Sales Revenue INMB (INmune Bio)|Barinthus Bio (BRNS) - Company Revenue|Kezar Life Sciences (KZR) - Revenue and Sales Volume|Company Revenue sabbiotherapeutics.com|Revenue and Sales Volume Akari Therapeutics Plc|Company Revenue Enlivex Therapeutics Ltd (ENLV)|Q32 Bio Corp (QTTB) - Company Total Sales Volume|Company Revenue GeoVax Corp GOVX|Company Gross Revenue Edesa Biotech Corp (EDSA)|IBIO: Company Sales|Company Sales Revenue CARM (carismatx.com)|XTLB: Revenue and Sales Volume|BOLT - Company Gross Revenue|Company Sales HCWB|Company Sales Aptevo Therapeutics Inc. (APVO)|Revenue and Sales Volume AIM|ADTX: Company Annual Revenue|GRI Bio - Company Sales|Company Gross Revenue XORTX Therapeutics Inc (XRTX)|HIND: Company Sales|Revelation Biosciences (REVB) - Company Sales|Indaptus Therapeutics, Inc. (INDP) - Company Revenue|SCNI - Company Gross Revenue|CALI (CalciMedica) - Revenue and Sales Volume|Revenue and Sales Volume affimed.com|Company Revenue Allakos Therapeutics (ALLK)|HOOK - Company Total Revenue|Company Revenue IGM Biosciences, Inc. IGMS|Company Gross Revenue iTeos Therapeutics, Inc. (ITOS)|Ocean Biomedical Corp - Revenue and Sales Volume|TC BioPharm (TCBP) - Company Sales|THRD: Revenue and Sales Volume